Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 and optimal volume of liposomal bupivacaine for ultrasound-guided superior trunk block in arthroscopic rotator cuff repair
ChiCTR2600123192Phase 4Not yet recruiting
- Sponsor
- Jiangsu Geriatric Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in postoperative pain, sponsored by Jiangsu Geriatric Hospital. Primary endpoint: MEV90 for successful analgesia at 24 hours. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600123192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123192.